Cargando…

Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy

IMPORTANCE: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating adverse effect of neurotoxic cancer treatments including taxanes and platinum agents. Limited knowledge exists of potential prechemotherapy factors associated with CIPN development. OBJECTIVE: To identify the association...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizrahi, David, Park, Susanna B., Li, Tiffany, Timmins, Hannah C., Trinh, Terry, Au, Kimberley, Battaglini, Eva, Wyld, David, Henderson, Robert D., Grimison, Peter, Ke, Helen, Geelan-Small, Peter, Marker, Julie, Wall, Brian, Goldstein, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885037/ https://www.ncbi.nlm.nih.gov/pubmed/33587134 http://dx.doi.org/10.1001/jamanetworkopen.2020.36695

Ejemplares similares

Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients
por: Mahfouz, Fawaz Mayez, et al.
Publicado: (2022)

Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxel
por: Chiang, Jeremy Chung Bo, et al.
Publicado: (2021)

Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy
por: Mizrahi, David, et al.
Publicado: (2022)

Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study
por: Hooshmand, Kosar, et al.
Publicado: (2022)

A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer
por: Chiang, Jeremy Chung Bo, et al.
Publicado: (2021)

Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use
por: Li, Tiffany, et al.
Publicado: (2022)

Management of oxaliplatin-induced peripheral neuropathy
por: Saif, M Wasif, et al.
Publicado: (2005)

Oxaliplatin-Induced Neuropathy in Colorectal Cancer
por: Weickhardt, Andrew, et al.
Publicado: (2011)

The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review
por: Gebremedhn, Endale Gebreegziabher, et al.
Publicado: (2018)

A Cross-Sectional Study of Sub-Basal Corneal Nerve Reduction Following Neurotoxic Chemotherapy
por: Chiang, Jeremy Chung Bo, et al.
Publicado: (2021)

Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
por: Cavaletti, Guido, et al.
Publicado: (2020)

Platinum accumulation in oxaliplatin‐induced peripheral neuropathy
por: Wei, Guoli, et al.
Publicado: (2021)

A predictive model for the critical shoulder angle based on a three-dimensional analysis of scapular angular and linear morphometrics
por: Smith, Geoffrey C. S., et al.
Publicado: (2022)

Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report
por: Anderson, Matthew A., et al.
Publicado: (2021)

Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy
por: Yoshida, Yoichiro, et al.
Publicado: (2015)

Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2017)

Paclitaxel/oxaliplatin/fluorouracil (TOF) regimen versus S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer patients
por: Dai, Xichao, et al.
Publicado: (2016)

A Prospective Study of Chronic Oxaliplatin-Induced Neuropathy in Patients with Colon Cancer: Long-Term Outcomes and Predictors of Severe Oxaliplatin-Induced Neuropathy
por: Kim, Su-Hyun, et al.
Publicado: (2018)

Primary pancreatic lymphoma – pancreatic tumours that are potentially curable without resection, a retrospective review of four cases
por: Grimison, Peter S, et al.
Publicado: (2006)

A fruit fly model for studying paclitaxel-induced peripheral neuropathy and hyperalgesia
por: Hamoudi, Zina, et al.
Publicado: (2018)

Berberine Alleviates Paclitaxel-Induced Neuropathy
por: Rezaee, Ramin, et al.
Publicado: (2019)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
por: Klein, Ines, et al.
Publicado: (2021)

Analgesic Effect of Melittin on Oxaliplatin-Induced Peripheral Neuropathy in Rats
por: Choi, Seunghwan, et al.
Publicado: (2019)

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
por: Giampieri, Riccardo, et al.
Publicado: (2019)

Metformin protects from oxaliplatin induced peripheral neuropathy in rats
por: Martinez, N.W., et al.
Publicado: (2020)

Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy
por: Egashira, Nobuaki
Publicado: (2021)

“POLAR-izing” Findings From Trials of Neuroprotection for Oxaliplatin Neuropathy
por: Teng, Christina, et al.
Publicado: (2022)

Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice
por: Renn, Cynthia L, et al.
Publicado: (2011)

Dose Effects of Oxaliplatin on Persistent and Transient Na(+) Conductances and the Development of Neurotoxicity
por: Park, Susanna B., et al.
Publicado: (2011)

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
por: Tsubaki, Masanobu, et al.
Publicado: (2023)

Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months
por: Zahrieh, David, et al.
Publicado: (2022)

Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
por: Park, Susanna B, et al.
Publicado: (2014)

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats
por: Lee, Jung Soo, et al.
Publicado: (2012)

Self-Management of Oxaliplatin-Related Peripheral Neuropathy in Colorectal Cancer Survivors
por: Tofthagen, Cindy, et al.
Publicado: (2013)

Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
por: Yoshida, Naohisa, et al.
Publicado: (2013)

Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats
por: Fujita, Shunsuke, et al.
Publicado: (2015)

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
por: Sereno, María, et al.
Publicado: (2017)

Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice
por: Pereira, A.F., et al.
Publicado: (2020)

Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro
por: Shigematsu, Nao, et al.
Publicado: (2020)

Oxaliplatin-induced peripheral neuropathy risk factors and management in Tunisian population
por: Zribi, Aref, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lg2ebqeeqgmrn6o36ac9iqujac